➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Mallinckrodt
Baxter
Colorcon
McKesson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CEFTAZIDIME IN DEXTROSE CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ceftazidime In Dextrose Container, and when can generic versions of Ceftazidime In Dextrose Container launch?

Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

US ANDA Litigation and Generic Entry Outlook for Ceftazidime In Dextrose Container

A generic version of CEFTAZIDIME IN DEXTROSE CONTAINER was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.

  Start Trial

Summary for CEFTAZIDIME IN DEXTROSE CONTAINER
Drug patent expirations by year for CEFTAZIDIME IN DEXTROSE CONTAINER
Recent Clinical Trials for CEFTAZIDIME IN DEXTROSE CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 2
AllerganPhase 2
AllerganPhase 1

See all CEFTAZIDIME IN DEXTROSE CONTAINER clinical trials

Pharmacology for CEFTAZIDIME IN DEXTROSE CONTAINER

US Patents and Regulatory Information for CEFTAZIDIME IN DEXTROSE CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823-001 Jun 13, 2011 RX Yes No   Start Trial   Start Trial   Start Trial
B Braun CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823-002 Jun 13, 2011 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Harvard Business School
Dow
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.